{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T17:56:05Z","timestamp":1794851765885,"version":"4.9.1"},"reference-count":164,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","surveyophthalmol.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Survey of Ophthalmology"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.survophthal.2023.04.003","type":"journal-article","created":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T20:49:05Z","timestamp":1683146945000},"page":"940-956","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Future directions in managing aniridia-associated keratopathy"],"prefix":"10.1016","volume":"68","author":[{"given":"Arianne J.H.","family":"van Velthoven","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tor P.","family":"Utheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Notara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Bremond-Gignac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco C.","family":"Figueiredo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heli","family":"Skottman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Aberdam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie T.","family":"Daniels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Grupcheva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carina","family":"Koppen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohit","family":"Parekh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Ritter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vito","family":"Romano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus","family":"Cursiefen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Lagali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa L.S.","family":"LaPointe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mor M.","family":"Dickman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.survophthal.2023.04.003_bib1","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3390\/pharmaceutics12040335","article-title":"Controlled release of rAAV vectors from APMA-functionalized contact lenses for corneal gene therapy","volume":"12","author":"Alvarez-Rivera","year":"2020","journal-title":"Pharmaceutics"},{"issue":"7114","key":"10.1016\/j.survophthal.2023.04.003_bib2","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/nature05249","article-title":"Corneal avascularity is due to soluble VEGF receptor-1","volume":"443","author":"Ambati","year":"2006","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.survophthal.2023.04.003_bib3","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/ICO.0b013e318255eac4","article-title":"Ocular surface stem cell transplantation rejection: incidence, characteristics, and outcomes","volume":"32","author":"Ang","year":"2013","journal-title":"Cornea"},{"issue":"2","key":"10.1016\/j.survophthal.2023.04.003_bib4","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.semcdb.2007.08.014","article-title":"Maintaining transparency: a review of the developmental physiology and pathophysiology of two avascular tissues","volume":"19","author":"Beebe","year":"2008","journal-title":"Semin Cell Dev Biol"},{"issue":"6","key":"10.1016\/j.survophthal.2023.04.003_bib5","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1097\/ICO.0000000000002282","article-title":"Development and validation of an open-source grading tool for outcome assessment in limbal stem cell treatment","volume":"39","author":"Behaegel","year":"2020","journal-title":"Cornea"},{"issue":"1","key":"10.1016\/j.survophthal.2023.04.003_bib6","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/ICO.0000000000002729","article-title":"Outcomes of human leukocyte antigen-matched allogeneic cultivated limbal epithelial transplantation in aniridia-associated keratopathy-a single-center retrospective analysis","volume":"41","author":"Behaegel","year":"2022","journal-title":"Cornea"},{"issue":"12","key":"10.1016\/j.survophthal.2023.04.003_bib7","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1097\/ICO.0000000000002153","article-title":"Short- and long-term results of xenogeneic-free cultivated autologous and allogeneic limbal epithelial stem cell transplantations","volume":"38","author":"Behaegel","year":"2019","journal-title":"Cornea"},{"issue":"9","key":"10.1016\/j.survophthal.2023.04.003_bib8","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.3390\/jcm8091478","article-title":"Blood-based treatments for severe dry eye disease: the need of a consensus","volume":"8","author":"Bernabei","year":"2019","journal-title":"J Clin Med"},{"issue":"6","key":"10.1016\/j.survophthal.2023.04.003_bib9","doi-asserted-by":"crossref","DOI":"10.1111\/jsr.12982","article-title":"Aniridia with PAX6 mutations and narcolepsy","volume":"29","author":"Berntsson","year":"2020","journal-title":"J Sleep Res"},{"issue":"2","key":"10.1016\/j.survophthal.2023.04.003_bib10","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1096\/fj.05-4737fje","article-title":"Plasmid electrotransfer of eye ciliary muscle: principles and therapeutic efficacy using hTNF-alpha soluble receptor in uveitis","volume":"20","author":"Bloquel","year":"2006","journal-title":"FASEB J"},{"key":"10.1016\/j.survophthal.2023.04.003_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2019.146307","article-title":"Early and late auditory information processing show opposing deviations in aniridia","volume":"1720","author":"Bobilev","year":"2019","journal-title":"Brain Res"},{"issue":"2","key":"10.1016\/j.survophthal.2023.04.003_bib12","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00417-007-0684-4","article-title":"Bevacizumab (Avastin) eye drops inhibit corneal neovascularization","volume":"246","author":"Bock","year":"2008","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"6","key":"10.1016\/j.survophthal.2023.04.003_bib13","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1167\/iovs.06-0570","article-title":"Bevacizumab as a potent inhibitor of inflammatory corneal angiogenesis and lymphangiogenesis","volume":"48","author":"Bock","year":"2007","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"11","key":"10.1016\/j.survophthal.2023.04.003_bib14","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1002\/stem.2903","article-title":"CD200 expression marks a population of quiescent limbal epithelial stem cells with holoclone forming ability","volume":"36","author":"Bojic","year":"2018","journal-title":"Stem Cells"},{"issue":"1","key":"10.1016\/j.survophthal.2023.04.003_bib15","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1186\/s13256-022-03502-8","article-title":"Transplantation of autologous cultivated oral mucosal epithelial sheets for limbal stem cell deficiency at Siriraj Hospital: a case series","volume":"16","author":"Booranapong","year":"2022","journal-title":"J Med Case Rep"},{"issue":"8","key":"10.1016\/j.survophthal.2023.04.003_bib16","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/j.drudis.2019.05.038","article-title":"Ocular gene therapies in clinical practice: viral vectors and nonviral alternatives","volume":"24","author":"Bordet","year":"2019","journal-title":"Drug Discov Today"},{"issue":"2","key":"10.1016\/j.survophthal.2023.04.003_bib17","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1755-3768.2012.02525.x","article-title":"Topical ranibizumab inhibits inflammatory corneal hem- and lymphangiogenesis","volume":"92","author":"Bucher","year":"2014","journal-title":"Acta Ophthalmol"},{"issue":"19","key":"10.1016\/j.survophthal.2023.04.003_bib18","doi-asserted-by":"crossref","first-page":"3434","DOI":"10.1093\/hmg\/ddy255","article-title":"Functional characteristics of novel pancreatic Pax6 regulatory elements","volume":"27","author":"Buckle","year":"2018","journal-title":"Hum Mol Genet"},{"issue":"3","key":"10.1016\/j.survophthal.2023.04.003_bib19","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/ICU.0000000000000359","article-title":"CRISPR applications in ophthalmologic genome surgery","volume":"28","author":"Cabral","year":"2017","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.survophthal.2023.04.003_bib20","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.trsl.2018.11.003","article-title":"A proof-of-concept clinical trial using mesenchymal stem cells for the treatment of corneal epithelial stem cell deficiency","volume":"206","author":"Calonge","year":"2019","journal-title":"Transl Res"},{"issue":"4","key":"10.1016\/j.survophthal.2023.04.003_bib21","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/sctm.18-0140","article-title":"Allogeneic ex vivo expanded corneal epithelial stem cell transplantation: a randomized controlled clinical trial","volume":"8","author":"Campbell","year":"2019","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.survophthal.2023.04.003_bib22","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.2147\/OPTH.S65298","article-title":"Chemical injury treated with autologous limbal epithelial stem cell transplantation and subconjunctival bevacizumab","volume":"8","author":"Cavallini","year":"2014","journal-title":"Clin Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2023.04.003_bib23","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1186\/s13287-018-1036-5","article-title":"Corneal cell therapy: with iPSCs, it is no more a far-sight","volume":"9","author":"Chakrabarty","year":"2018","journal-title":"Stem Cell Res Ther"},{"issue":"8","key":"10.1016\/j.survophthal.2023.04.003_bib24","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1097\/ICO.0000000000002329","article-title":"Long-term outcomes of living-related conjunctival limbal allograft compared with keratolimbal allograft in patients with limbal stem cell deficiency","volume":"39","author":"Cheung","year":"2020","journal-title":"Cornea"},{"key":"10.1016\/j.survophthal.2023.04.003_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2022.109012","article-title":"Long-term retinal protection by MEK inhibition in Pax6 haploinsufficiency mice","volume":"218","author":"Cole","year":"2022","journal-title":"Exp Eye Res"},{"issue":"5","key":"10.1016\/j.survophthal.2023.04.003_bib26","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1086\/344396","article-title":"Frequent chromosome aberrations revealed by molecular cytogenetic studies in patients with aniridia","volume":"71","author":"Crolla","year":"2002","journal-title":"Am J Hum Genet"},{"issue":"9","key":"10.1016\/j.survophthal.2023.04.003_bib27","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/j.ophtha.2009.04.016","article-title":"GS-101 antisense oligonucleotide eye drops inhibit corneal neovascularization: interim results of a randomized phase II trial","volume":"116","author":"Cursiefen","year":"2009","journal-title":"Ophthalmology"},{"issue":"8","key":"10.1016\/j.survophthal.2023.04.003_bib28","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1167\/iovs.03-1380","article-title":"Inhibition of hemangiogenesis and lymphangiogenesis after normal-risk corneal transplantation by neutralizing VEGF promotes graft survival","volume":"45","author":"Cursiefen","year":"2004","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.survophthal.2023.04.003_bib29","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/bjo.87.1.101","article-title":"Pericyte recruitment in human corneal angiogenesis: an ultrastructural study with clinicopathological correlation","volume":"87","author":"Cursiefen","year":"2003","journal-title":"Br J Ophthalmol"},{"issue":"9","key":"10.1016\/j.survophthal.2023.04.003_bib30","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/j.ophtha.2014.03.038","article-title":"Aganirsen antisense oligonucleotide eye drops inhibit keratitis-induced corneal neovascularization and reduce need for transplantation: the I-CAN study","volume":"121","author":"Cursiefen","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2023.04.003_bib31","doi-asserted-by":"crossref","DOI":"10.1038\/d41586-019-02597-2","article-title":"Woman is first to receive cornea made from 'reprogrammed' stem cells","author":"Cyranoski","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.survophthal.2023.04.003_bib32","first-page":"101133","article-title":"Congenital aniridia beyond black eyes: from phenotype and novel genetic mechanisms to innovative therapeutic approaches","author":"Daruich","year":"2022","journal-title":"Prog Retin Eye Res"},{"issue":"7","key":"10.1016\/j.survophthal.2023.04.003_bib33","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.1167\/iovs.10-6726","article-title":"Overexpression of Pax6 in mouse cornea directly alters corneal epithelial cells: changes in immune function, vascularization, and differentiation","volume":"52","author":"Davis","year":"2011","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"3","key":"10.1016\/j.survophthal.2023.04.003_bib34","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.ophtha.2004.09.023","article-title":"Outcomes and DNA analysis of ex vivo expanded stem cell allograft for ocular surface reconstruction","volume":"112","author":"Daya","year":"2005","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.survophthal.2023.04.003_bib35","doi-asserted-by":"crossref","first-page":"791","DOI":"10.3390\/pharmaceutics14040791","article-title":"Mesenchymal stem\/stromal cells in organ transplantation","volume":"14","author":"Deo","year":"2022","journal-title":"Pharmaceutics"},{"issue":"5","key":"10.1016\/j.survophthal.2023.04.003_bib36","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.1167\/iovs.12-10856","article-title":"Sunitinib inhibits inflammatory corneal lymphangiogenesis","volume":"54","author":"Detry","year":"2013","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"3","key":"10.1016\/j.survophthal.2023.04.003_bib37","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1167\/iovs.04-0575","article-title":"Survival of donor epithelial cells after limbal stem cell transplantation","volume":"46","author":"Djalilian","year":"2005","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.survophthal.2023.04.003_bib38","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3390\/pharmaceutics13010007","article-title":"Formulation and stability of ataluren eye drop oily solution for aniridia","volume":"13","author":"Djayet","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.survophthal.2023.04.003_bib39","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/281870","article-title":"Cultivated oral mucosa epithelium in ocular surface reconstruction in aniridia patients","volume":"2015","author":"Dobrowolski","year":"2015","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.survophthal.2023.04.003_bib40","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jtos.2021.12.003","article-title":"The antipsychotropic drug duloxetine rescues PAX6 haploinsufficiency of mutant limbal stem cells through inhibition of the MEK\/ERK signaling pathway","volume":"23","author":"Dorot","year":"2022","journal-title":"Ocul Surf"},{"issue":"7","key":"10.1016\/j.survophthal.2023.04.003_bib41","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1136\/bjophthalmol-2015-307935","article-title":"Amnion-assisted conjunctival epithelial redirection in limbal stem cell grafting","volume":"101","author":"Dua","year":"2017","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2023.04.003_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.749063","article-title":"Long-term anatomical and functional survival of Boston type 1 keratoprosthesis in congenital aniridia","volume":"8","author":"Dyer","year":"2021","journal-title":"Front Med"},{"issue":"5","key":"10.1016\/j.survophthal.2023.04.003_bib43","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.ophtha.2011.10.039","article-title":"Allogenic limbo-keratoplasty with conjunctivoplasty, mitomycin C, and amniotic membrane for bilateral limbal stem cell deficiency","volume":"119","author":"Eberwein","year":"2012","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1016\/j.survophthal.2023.04.003_bib44","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/j.ophtha.2012.02.043","article-title":"Pathologic epithelial and anterior corneal nerve morphology in early-stage congenital aniridic keratopathy","volume":"119","author":"Eden","year":"2012","journal-title":"Ophthalmology"},{"issue":"10","key":"10.1016\/j.survophthal.2023.04.003_bib45","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1097\/ICO.0b013e3181d20493","article-title":"Corneal involvement in congenital aniridia","volume":"29","author":"Eden","year":"2010","journal-title":"Cornea"},{"issue":"6","key":"10.1016\/j.survophthal.2023.04.003_bib46","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1080\/17434440.2020.1761788","article-title":"Device profile of the EYEMATE-IO system for intraocular pressure monitoring: overview of its safety and efficacy","volume":"17","author":"Enders","year":"2020","journal-title":"Expert Rev Med Devices"},{"key":"10.1016\/j.survophthal.2023.04.003_bib47","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.ajo.2019.02.025","article-title":"Telemetric intraocular pressure monitoring after boston keratoprosthesis surgery using the Eyemate-IO Sensor: dynamics in the first year","volume":"206","author":"Enders","year":"2019","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2023.04.003_bib48","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.ophtha.2018.09.028","article-title":"Telemetric intraocular pressure monitoring after Boston keratoprosthesis surgery","volume":"126","author":"Enders","year":"2019","journal-title":"Ophthalmology"},{"issue":"7","key":"10.1016\/j.survophthal.2023.04.003_bib49","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1097\/ICO.0b013e3182775f8d","article-title":"Topical Ranibizumab as a treatment of corneal neovascularization","volume":"32","author":"Ferrari","year":"2013","journal-title":"Cornea"},{"issue":"11","key":"10.1016\/j.survophthal.2023.04.003_bib50","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1136\/bjo.2004.044347","article-title":"Autologous serum eye drops for ocular surface disorders","volume":"88","author":"Geerling","year":"2004","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"10.1016\/j.survophthal.2023.04.003_bib51","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/jgm.876","article-title":"Influence of local and systemic CTLA4Ig gene transfer on corneal allograft survival","volume":"8","author":"Gong","year":"2006","journal-title":"J Gene Med"},{"issue":"1","key":"10.1016\/j.survophthal.2023.04.003_bib52","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1038\/s41467-019-09331-6","article-title":"Assessment of corneal substrate biomechanics and its effect on epithelial stem cell maintenance and differentiation","volume":"10","author":"Gouveia","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.survophthal.2023.04.003_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2021.147283","article-title":"Structural and functional consequences of PAX6 mutations in the brain: implications for aniridia","volume":"1756","author":"Grant","year":"2021","journal-title":"Brain Res"},{"issue":"1","key":"10.1016\/j.survophthal.2023.04.003_bib54","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1172\/JCI70462","article-title":"Postnatal manipulation of Pax6 dosage reverses congenital tissue malformation defects","volume":"124","author":"Gregory-Evans","year":"2014","journal-title":"J Clin Investig"},{"issue":"3\u20134","key":"10.1016\/j.survophthal.2023.04.003_bib55","first-page":"82","article-title":"Application of the amniotic membrane in ocular surface pathology","volume":"4","author":"Gris","year":"1999","journal-title":"Ann Transplant"},{"issue":"3","key":"10.1016\/j.survophthal.2023.04.003_bib56","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/BF02829578","article-title":"Effects of CTLA4-Ig gene-modified dendritic cells on the corneal allografts","volume":"26","author":"Han","year":"2006","journal-title":"J Huazhong Univ Sci Technol Med Sci"},{"issue":"3","key":"10.1016\/j.survophthal.2023.04.003_bib57","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1002\/stem.1895","article-title":"Concise reviews: can mesenchymal stromal cells differentiate into corneal cells? A systematic review of published data","volume":"33","author":"Harkin","year":"2015","journal-title":"Stem Cells"},{"issue":"5","key":"10.1016\/j.survophthal.2023.04.003_bib58","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1136\/bjo.85.5.604","article-title":"The long term outcome of limbal allografts: the search for surviving cells","volume":"85","author":"Henderson","year":"2001","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2023.04.003_bib59","doi-asserted-by":"crossref","DOI":"10.1038\/mtm.2016.51","article-title":"PAX6 minipromoters drive restricted expression from rAAV in the adult mouse retina","volume":"3","author":"Hickmott","year":"2016","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"8","key":"10.1016\/j.survophthal.2023.04.003_bib60","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1097\/01.ico.0000157401.81408.62","article-title":"Standards for modified osteoodontokeratoprosthesis (OOKP) surgery according to strampelli and falcinelli: the Rome-Vienna Protocol","volume":"24","author":"Hille","year":"2005","journal-title":"Cornea"},{"issue":"6","key":"10.1016\/j.survophthal.2023.04.003_bib61","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1167\/iovs.08-2827","article-title":"Detailed ophthalmologic evaluation of 43 individuals with PAX6 mutations","volume":"50","author":"Hingorani","year":"2009","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.survophthal.2023.04.003_bib62","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/s41392-022-01134-4","article-title":"Stem cell-based therapy for human diseases","volume":"7","author":"Hoang","year":"2022","journal-title":"Signal Transduct Target Ther"},{"issue":"9","key":"10.1016\/j.survophthal.2023.04.003_bib63","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.5966\/sctm.2015-0039","article-title":"A comparative study of the therapeutic potential of mesenchymal stem cells and limbal epithelial stem cells for ocular surface reconstruction","volume":"4","author":"Holan","year":"2015","journal-title":"Stem Cells Transl Med"},{"issue":"1","key":"10.1016\/j.survophthal.2023.04.003_bib64","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0161-6420(02)01451-3","article-title":"Management of aniridic keratopathy with keratolimbal allograft: a limbal stem cell transplantation technique","volume":"110","author":"Holland","year":"2003","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.survophthal.2023.04.003_bib65","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/ICO.0b013e31823f8b0c","article-title":"Systemic immunosuppression in ocular surface stem cell transplantation: results of a 10-year experience","volume":"31","author":"Holland","year":"2012","journal-title":"Cornea"},{"issue":"5","key":"10.1016\/j.survophthal.2023.04.003_bib66","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1167\/iovs.07-1314","article-title":"Inflammatory corneal (lymph)angiogenesis is blocked by VEGFR-tyrosine kinase inhibitor ZK 261991, resulting in improved graft survival after corneal transplantation","volume":"49","author":"Hos","year":"2008","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2023.04.003_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2019.07.001","article-title":"Immune reactions after modern lamellar (DALK, DSAEK, DMEK) versus conventional penetrating corneal transplantation","volume":"73","author":"Hos","year":"2019","journal-title":"Prog Retin Eye Res"},{"issue":"8","key":"10.1016\/j.survophthal.2023.04.003_bib68","doi-asserted-by":"crossref","first-page":"5778","DOI":"10.1167\/iovs.10-6816","article-title":"Blockade of insulin receptor substrate-1 inhibits corneal lymphangiogenesis","volume":"52","author":"Hos","year":"2011","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"4","key":"10.1016\/j.survophthal.2023.04.003_bib69","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1001\/archophthalmol.2011.42","article-title":"Suppression of iflammatory corneal lymphangiogenesis by application of topical corticosteroids","volume":"129","author":"Hos","year":"2011","journal-title":"Arch Ophthalmol"},{"issue":"13","key":"10.1016\/j.survophthal.2023.04.003_bib70","doi-asserted-by":"crossref","first-page":"5862","DOI":"10.1167\/iovs.17-22904","article-title":"Photodynamic therapy leads to time-dependent regression of pathologic corneal (lymph) angiogenesis and promotes high-risk corneal allograft survival","volume":"58","author":"Hou","year":"2017","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"12","key":"10.1016\/j.survophthal.2023.04.003_bib71","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1111\/ajt.14874","article-title":"UV light crosslinking regresses mature corneal blood and lymphatic vessels and promotes subsequent high-risk corneal transplant survival","volume":"18","author":"Hou","year":"2018","journal-title":"Am J Transplant"},{"issue":"2","key":"10.1016\/j.survophthal.2023.04.003_bib72","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jtos.2015.10.003","article-title":"Congenital aniridia and the ocular surface","volume":"14","author":"Ihnatko","year":"2016","journal-title":"Ocul Surf"},{"key":"10.1016\/j.survophthal.2023.04.003_bib73","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jprot.2013.09.003","article-title":"Analysis of protein composition and protein expression in the tear fluid of patients with congenital aniridia","volume":"94","author":"Ihnatko","year":"2013","journal-title":"J Proteomics"},{"issue":"3","key":"10.1016\/j.survophthal.2023.04.003_bib74","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jtos.2018.03.008","article-title":"Corneal lymphangiogenesis facilitates ocular surface inflammation and cell trafficking in dry eye disease","volume":"16","author":"Ji","year":"2018","journal-title":"Ocul Surf"},{"key":"10.1016\/j.survophthal.2023.04.003_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2021.108904","article-title":"Decreased FABP5 and DSG1 protein expression following PAX6 knockdown of differentiated human limbal epithelial cells","volume":"215","author":"Katiyar","year":"2022","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.survophthal.2023.04.003_bib76","first-page":"2727","article-title":"Subepithelial corneal fibrosis partially due to epithelial-mesenchymal transition of ocular surface epithelium","volume":"16","author":"Kawashima","year":"2010","journal-title":"Mol Vis"},{"issue":"2","key":"10.1016\/j.survophthal.2023.04.003_bib77","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.ydbio.2006.08.060","article-title":"Long-range downstream enhancers are essential for Pax6 expression","volume":"299","author":"Kleinjan","year":"2006","journal-title":"Dev Biol"},{"issue":"8","key":"10.1016\/j.survophthal.2023.04.003_bib78","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1097\/ICO.0b013e31823f8f7a","article-title":"Angioregressive pretreatment of mature corneal blood vessels before keratoplasty: fine-needle vessel coagulation combined with anti-VEGFs","volume":"31","author":"Koenig","year":"2012","journal-title":"Cornea"},{"issue":"17","key":"10.1016\/j.survophthal.2023.04.003_bib79","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1093\/hmg\/ddq237","article-title":"Reduced expression of Pax6 in lens and cornea of mutant mice leads to failure of chamber angle development and juvenile glaucoma","volume":"19","author":"Kroeber","year":"2010","journal-title":"Hum Mol Genet"},{"issue":"8","key":"10.1016\/j.survophthal.2023.04.003_bib80","doi-asserted-by":"crossref","first-page":"5333","DOI":"10.1167\/iovs.13-11780","article-title":"In vivo morphology of the limbal palisades of vogt correlates with progressive stem cell deficiency in aniridia-related keratopathy","volume":"54","author":"Lagali","year":"2013","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"6","key":"10.1016\/j.survophthal.2023.04.003_bib81","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1167\/iovs.08-2923","article-title":"Survival of donor-derived cells in human corneal transplants","volume":"50","author":"Lagali","year":"2009","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.survophthal.2023.04.003_bib82","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jtos.2017.11.003","article-title":"Stage-related central corneal epithelial transformation in congenital aniridia-associated keratopathy","volume":"16","author":"Lagali","year":"2018","journal-title":"Ocul Surf"},{"issue":"2","key":"10.1016\/j.survophthal.2023.04.003_bib83","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ophtha.2019.09.034","article-title":"PAX6 mutational status determines aniridia-associated keratopathy phenotype","volume":"127","author":"Lagali","year":"2020","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.survophthal.2023.04.003_bib84","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jtos.2019.11.002","article-title":"Early phenotypic features of aniridia-associated keratopathy and association with PAX6 coding mutations","volume":"18","author":"Lagali","year":"2020","journal-title":"Ocul Surf"},{"issue":"6","key":"10.1016\/j.survophthal.2023.04.003_bib85","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.survophthal.2021.02.011","article-title":"Congenital aniridia - a comprehensive review of clinical features and therapeutic approaches","volume":"66","author":"Landsend","year":"2021","journal-title":"Surv Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2023.04.003_bib86","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1136\/bjophthalmol-2017-310927","article-title":"Meibomian gland dysfunction and keratopathy are associated with dry eye disease in aniridia","volume":"103","author":"Landsend","year":"2019","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"10.1016\/j.survophthal.2023.04.003_bib87","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1167\/iovs.18-24027","article-title":"The level of inflammatory tear cytokines is elevated in congenital aniridia and associated with meibomian gland dysfunction","volume":"59","author":"Landsend","year":"2018","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.survophthal.2023.04.003_bib88","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.survophthal.2017.09.004","article-title":"The genetics of congenital aniridia - a guide for the ophthalmologist","volume":"63","author":"Landsend","year":"2018","journal-title":"Surv Ophthalmol"},{"issue":"4","key":"10.1016\/j.survophthal.2023.04.003_bib89","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1007\/s10792-017-0605-4","article-title":"Topical Bevacizumab treatment in aniridia","volume":"38","author":"Lapid-Gortzak","year":"2018","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.survophthal.2023.04.003_bib90","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jtos.2021.09.001","article-title":"Pathophysiology of aniridia-associated keratopathy: developmental aspects and unanswered questions","volume":"22","author":"Latta","year":"2021","journal-title":"Ocul Surf"},{"key":"10.1016\/j.survophthal.2023.04.003_bib91","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jtos.2020.04.014","article-title":"Abnormal neovascular and proliferative conjunctival phenotype in limbal stem cell deficiency is associated with altered microRNA and gene expression modulated by PAX6 mutational status in congenital aniridia","volume":"19","author":"Latta","year":"2021","journal-title":"Ocul Surf"},{"key":"10.1016\/j.survophthal.2023.04.003_bib92","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.exer.2018.10.002","article-title":"Expression of retinoic acid signaling components ADH7 and ALDH1A1 is reduced in aniridia limbal epithelial cells and a siRNA primary cell based aniridia model","volume":"179","author":"Latta","year":"2019","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.survophthal.2023.04.003_bib93","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.exer.2017.11.005","article-title":"Human aniridia limbal epithelial cells lack expression of keratins K3 and K12","volume":"167","author":"Latta","year":"2018","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.survophthal.2023.04.003_bib94","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.681320","article-title":"Clinical insights into novel immune checkpoint inhibitors","volume":"12","author":"Lee","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.survophthal.2023.04.003_bib95","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ajo.2017.10.017","article-title":"Corneal abnormalities in congenital aniridia: congenital central corneal opacity versus aniridia-associated keratopathy","volume":"185","author":"Lee","year":"2018","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"10.1016\/j.survophthal.2023.04.003_bib96","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1001\/jamaophthalmol.2020.1120","article-title":"Outcomes of limbal stem cell transplant: a meta-analysis","volume":"138","author":"Le","year":"2020","journal-title":"JAMA Ophthalmol"},{"issue":"6","key":"10.1016\/j.survophthal.2023.04.003_bib97","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/eye.2013.50","article-title":"In vivo confocal microscopy of congenital aniridia-associated keratopathy","volume":"27","author":"Le","year":"2013","journal-title":"Eye"},{"issue":"1","key":"10.1016\/j.survophthal.2023.04.003_bib98","doi-asserted-by":"crossref","first-page":"3908","DOI":"10.1038\/s41598-020-60705-z","article-title":"Supplemental anti Vegf a-therapy prevents rebound neovascularisation after fine needle diathermy treatment to regress pathological corneal (LYMPH) angiogenesis","volume":"10","author":"Le","year":"2020","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.survophthal.2023.04.003_bib99","doi-asserted-by":"crossref","first-page":"5707","DOI":"10.1038\/s41598-018-24037-3","article-title":"Fine needle-diathermy regresses pathological corneal (lymph)angiogenesis and promotes high-risk corneal transplant survival","volume":"8","author":"Le","year":"2018","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.survophthal.2023.04.003_bib100","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s00417-014-2626-2","article-title":"Blockade of the VEGF isoforms in inflammatory corneal hemangiogenesis and lymphangiogenesis","volume":"252","author":"Lipp","year":"2014","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"5","key":"10.1016\/j.survophthal.2023.04.003_bib101","doi-asserted-by":"crossref","DOI":"10.1002\/mgg3.1198","article-title":"Nonsense suppression induced readthrough of a novel PAX6 mutation in patient-derived cells of congenital aniridia","volume":"8","author":"Liu","year":"2020","journal-title":"Mol Genet Genomic Med"},{"issue":"1","key":"10.1016\/j.survophthal.2023.04.003_bib102","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/path.2256","article-title":"Down-regulation of Pax6 is associated with abnormal differentiation of corneal epithelial cells in severe ocular surface diseases","volume":"214","author":"Li","year":"2008","journal-title":"J Pathol"},{"issue":"2","key":"10.1016\/j.survophthal.2023.04.003_bib103","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.ophtha.2007.03.087","article-title":"Autologous serum eyedrops in the treatment of aniridic keratopathy","volume":"115","author":"Lopez-Garcia","year":"2008","journal-title":"Ophthalmology"},{"issue":"11","key":"10.1016\/j.survophthal.2023.04.003_bib104","doi-asserted-by":"crossref","first-page":"5976","DOI":"10.3390\/ijms22115976","article-title":"Can human oral mucosa stem cells differentiate to corneal epithelia?","volume":"22","author":"Lopez","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.survophthal.2023.04.003_bib105","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.ymthe.2020.11.029","article-title":"Clinical perspective: treating RPE65-associated retinal dystrophy","volume":"29","author":"Maguire","year":"2021","journal-title":"Mol Ther"},{"issue":"11","key":"10.1016\/j.survophthal.2023.04.003_bib106","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/s41573-020-0083-7","article-title":"Modulating gene regulation to treat genetic disorders","volume":"19","author":"Matharu","year":"2020","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"10.1016\/j.survophthal.2023.04.003_bib107","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1186\/s13287-021-02564-7","article-title":"Long-term survival of cultivated oral mucosal epithelial cells in human cornea: generating cell sheets using an animal product-free culture protocol","volume":"12","author":"Ma","year":"2021","journal-title":"Stem Cell Res Ther"},{"issue":"7","key":"10.1016\/j.survophthal.2023.04.003_bib108","first-page":"1","article-title":"Limbal stem cell transplantation: an evidence-based analysis","volume":"8","author":"Medical Advisory","year":"2008","journal-title":"Ont Health Technol Assess Ser"},{"key":"10.1016\/j.survophthal.2023.04.003_bib109","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.exer.2015.11.021","article-title":"Human pluripotent stem cell-derived limbal epithelial stem cells on bioengineered matrices for corneal reconstruction","volume":"146","author":"Mikhailova","year":"2016","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.survophthal.2023.04.003_bib110","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.omtm.2020.03.002","article-title":"Germline CRISPR\/Cas9-mediated gene editing prevents vision loss in a novel mouse model of aniridia","volume":"17","author":"Mirjalili Mohanna","year":"2020","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1016\/j.survophthal.2023.04.003_bib111","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.108647","article-title":"An overview of immune checkpoint therapy in autoimmune diseases","volume":"107","author":"Mohammadi","year":"2022","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.survophthal.2023.04.003_bib112","unstructured":"Moshirfar M., Hastings J., Ronquillo Y. Aniridic fibrosis syndrome. StatPearls. Treasure Island, FL, 2022."},{"issue":"6","key":"10.1016\/j.survophthal.2023.04.003_bib113","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/MOT.0000000000000360","article-title":"Mesenchymal stem cell therapy to promote corneal allograft survival: current status and pathway to clinical translation","volume":"21","author":"Murphy","year":"2016","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1016\/j.survophthal.2023.04.003_bib114","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.2147\/OPTH.S165553","article-title":"Amniotic membrane extract and eye drops: a review of literature and clinical application","volume":"12","author":"Murri","year":"2018","journal-title":"Clin Ophthalmol"},{"issue":"6","key":"10.1016\/j.survophthal.2023.04.003_bib115","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/0039-6257(84)90184-X","article-title":"A review","volume":"28","author":"Nelson","year":"1984","journal-title":"Surv Ophthalmol"},{"issue":"6","key":"10.1016\/j.survophthal.2023.04.003_bib116","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.jaapos.2011.07.009","article-title":"Ocular and systemic findings in a survey of aniridia subjects","volume":"15","author":"Netland","year":"2011","journal-title":"J AAPOS"},{"issue":"1","key":"10.1016\/j.survophthal.2023.04.003_bib117","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/s13287-021-02272-2","article-title":"Process development and safety evaluation of ABCB5(+) limbal stem cells as advanced-therapy medicinal product to treat limbal stem cell deficiency","volume":"12","author":"Norrick","year":"2021","journal-title":"Stem Cell Res Ther"},{"issue":"11","key":"10.1016\/j.survophthal.2023.04.003_bib118","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.3390\/jcm8111925","article-title":"Bevacizumab induces upregulation of keratin 3 and VEGFA in human limbal epithelial cells in vitro","volume":"8","author":"Notara","year":"2019","journal-title":"J Clin Med"},{"issue":"6","key":"10.1016\/j.survophthal.2023.04.003_bib119","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s10384-010-0879-9","article-title":"Simultaneous deep anterior lamellar keratoplasty and limbal allograft in bilateral limbal stem cell deficiency","volume":"54","author":"Omoto","year":"2010","journal-title":"Jpn J Ophthalmol"},{"issue":"3","key":"10.1016\/j.survophthal.2023.04.003_bib120","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1167\/iovs.09-4023","article-title":"Cytoskeletal and cell adhesion defects in wounded and Pax6+\/- corneal epithelia","volume":"51","author":"Ou","year":"2010","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"4","key":"10.1016\/j.survophthal.2023.04.003_bib121","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/path.2371","article-title":"Chronic wound state exacerbated by oxidative stress in Pax6+\/- aniridia-related keratopathy","volume":"215","author":"Ou","year":"2008","journal-title":"J Pathol"},{"key":"10.1016\/j.survophthal.2023.04.003_bib122","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.bbrc.2021.10.036","article-title":"Ritanserin, a potent Serotonin 2A receptor antagonist, represses MEK\/ERK signalling pathway to restore PAX6 production and function in aniridia-like cellular model","volume":"582","author":"Oved","year":"2021","journal-title":"Biochem Biophys Res Commun"},{"issue":"7","key":"10.1016\/j.survophthal.2023.04.003_bib123","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/j.1755-3768.2008.01293.x","article-title":"Long-term visual prognosis of corneal and ocular surface surgery in patients with congenital aniridia","volume":"86","author":"de la Paz","year":"2008","journal-title":"Acta Ophthalmol"},{"issue":"9057","key":"10.1016\/j.survophthal.2023.04.003_bib124","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/S0140-6736(96)11188-0","article-title":"Long-term restoration of damaged corneal surfaces with autologous cultivated corneal epithelium","volume":"349","author":"Pellegrini","year":"1997","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.survophthal.2023.04.003_bib125","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/s42003-021-02237-4","article-title":"Immunological considerations and challenges for regenerative cellular therapies","volume":"4","author":"Petrus-Reurer","year":"2021","journal-title":"Commun Biol"},{"issue":"7","key":"10.1016\/j.survophthal.2023.04.003_bib126","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1097\/ICO.0000000000002498","article-title":"Phenotypic characterization of corneal epithelium in long-term follow-up of patients post-autologous cultivated oral mucosal epithelial transplantation","volume":"40","author":"Prabhasawat","year":"2021","journal-title":"Cornea"},{"issue":"573","key":"10.1016\/j.survophthal.2023.04.003_bib127","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaz4894","article-title":"Gene dosage manipulation alleviates manifestations of hereditary PAX6 haploinsufficiency in mice","volume":"12","author":"Rabiee","year":"2020","journal-title":"Sci Transl Med"},{"issue":"10","key":"10.1016\/j.survophthal.2023.04.003_bib128","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1038\/eye.2008.410","article-title":"Amniotic membrane in ophthalmology: indications and limitations","volume":"23","author":"Rahman","year":"2009","journal-title":"Eye"},{"issue":"1","key":"10.1016\/j.survophthal.2023.04.003_bib129","article-title":"Proof-of-Concept study of electrospun PLGA membrane in the treatment of limbal stem cell deficiency","volume":"6","author":"Ramachandran","year":"2021","journal-title":"BMJ Open Ophthalmol"},{"issue":"3","key":"10.1016\/j.survophthal.2023.04.003_bib130","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.biocel.2004.09.002","article-title":"Evolving concepts on the pathogenic mechanisms of aniridia related keratopathy","volume":"37","author":"Ramaesh","year":"2005","journal-title":"Int J Biochem Cell Biol"},{"issue":"2","key":"10.1016\/j.survophthal.2023.04.003_bib131","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1056\/NEJMoa0905955","article-title":"Limbal stem-cell therapy and long-term corneal regeneration","volume":"363","author":"Rama","year":"2010","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.survophthal.2023.04.003_bib132","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.ophtha.2003.07.013","article-title":"Long-term results of allogeneic penetrating limbo-keratoplasty in total limbal stem cell deficiency","volume":"111","author":"Reinhard","year":"2004","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.survophthal.2023.04.003_bib133","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s11095-018-2554-7","article-title":"Pharmaceutical development of AAV-based gene therapy products for the eye","volume":"36","author":"Rodrigues","year":"2018","journal-title":"Pharm Res"},{"issue":"9","key":"10.1016\/j.survophthal.2023.04.003_bib134","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1002\/stem.2858","article-title":"Modeling of aniridia-related keratopathy by CRISPR\/Cas9 genome editing of human limbal epithelial cells and rescue by recombinant PAX6 protein","volume":"36","author":"Roux","year":"2018","journal-title":"Stem Cells"},{"key":"10.1016\/j.survophthal.2023.04.003_bib135","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3389\/fmed.2020.00043","article-title":"Clinical outcomes from cultivated allogenic stem cells vs. oral mucosa epithelial transplants in total bilateral stem cells deficiency","volume":"7","author":"Samoila","year":"2020","journal-title":"Front Med"},{"issue":"2","key":"10.1016\/j.survophthal.2023.04.003_bib136","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/ICO.0000000000002406","article-title":"Corneal crosslinking to regress pathologic corneal neovascularization before high-risk keratoplasty","volume":"40","author":"Schaub","year":"2021","journal-title":"Cornea"},{"issue":"6","key":"10.1016\/j.survophthal.2023.04.003_bib137","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1007\/s00347-021-01356-x","article-title":"Treatment of vascularized high-risk eyes with a Boston keratoprosthesis","volume":"118","author":"Schaub","year":"2021","journal-title":"Ophthalmologe"},{"issue":"4","key":"10.1016\/j.survophthal.2023.04.003_bib138","first-page":"327","article-title":"The emerging technology of tissue engineering: focus on stem cell niche","volume":"114","author":"Schlotzer-Schrehardt","year":"2017","journal-title":"Ophthalmologe"},{"key":"10.1016\/j.survophthal.2023.04.003_bib139","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jtos.2021.06.002","article-title":"Dysfunction of the limbal epithelial stem cell niche in aniridia-associated keratopathy","volume":"21","author":"Schlotzer-Schrehardt","year":"2021","journal-title":"Ocul Surf"},{"issue":"4","key":"10.1016\/j.survophthal.2023.04.003_bib140","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1089\/jop.2019.0147","article-title":"Short-term results analysis in the allogenic transplantation of limbal stem cells expanded on amniotic membrane in patients with bilateral limbal stem cell deficiency","volume":"36","author":"Serna-Ojeda","year":"2020","journal-title":"J Ocul Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.survophthal.2023.04.003_bib141","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/ICO.0000000000001412","article-title":"Intermediate-term and long-term outcomes with the Boston type 1 keratoprosthesis in aniridia","volume":"37","author":"Shah","year":"2018","journal-title":"Cornea"},{"issue":"1","key":"10.1016\/j.survophthal.2023.04.003_bib142","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2169\/internalmedicine.53.1184","article-title":"Aniridia with a heterozygous PAX6 mutation in which the pituitary function was partially impaired","volume":"53","author":"Shimo","year":"2014","journal-title":"Intern Med"},{"issue":"10","key":"10.1016\/j.survophthal.2023.04.003_bib143","first-page":"696","article-title":"CTLA4-Ig prevents corneal allograft rejection in mice","volume":"40","author":"Shi","year":"2004","journal-title":"Zhonghua Yan Ke Za Zhi"},{"issue":"2","key":"10.1016\/j.survophthal.2023.04.003_bib144","doi-asserted-by":"crossref","first-page":"265","DOI":"10.5966\/sctm.2013-0025","article-title":"Three-year outcomes of cultured limbal epithelial allografts in aniridia and Stevens-Johnson syndrome evaluated using the clinical outcome assessment in surgical trials assessment tool","volume":"3","author":"Shortt","year":"2014","journal-title":"Stem Cells Transl Med"},{"issue":"2","key":"10.1016\/j.survophthal.2023.04.003_bib145","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s00417-015-3200-2","article-title":"Systemic immunosuppression with mycophenolate mofetil to prevent corneal graft rejection after high-risk penetrating keratoplasty: a 2-year follow-up study","volume":"254","author":"Szaflik","year":"2016","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"12","key":"10.1016\/j.survophthal.2023.04.003_bib146","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1038\/nprot.2007.418","article-title":"Induction of pluripotent stem cells from fibroblast cultures","volume":"2","author":"Takahashi","year":"2007","journal-title":"Nat Protoc"},{"issue":"9","key":"10.1016\/j.survophthal.2023.04.003_bib147","doi-asserted-by":"crossref","first-page":"5774","DOI":"10.4049\/jimmunol.175.9.5774","article-title":"Differential effects of B and T lymphocyte attenuator and programmed death-1 on acceptance of partially versus fully MHC-mismatched cardiac allografts","volume":"175","author":"Tao","year":"2005","journal-title":"J Immunol"},{"issue":"8","key":"10.1016\/j.survophthal.2023.04.003_bib148","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.molmed.2018.06.006","article-title":"Seeing the light after 25 years of retinal gene therapy","volume":"24","author":"Trapani","year":"2018","journal-title":"Trends Mol Med"},{"issue":"6","key":"10.1016\/j.survophthal.2023.04.003_bib149","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.ajo.2005.07.035","article-title":"A progressive anterior fibrosis syndrome in patients with postsurgical congenital aniridia","volume":"140","author":"Tsai","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2023.04.003_bib150","doi-asserted-by":"crossref","unstructured":"Utheim T.P. Limbal epithelial cell therapy: past, present, and future. Methods Mol Biol. 2013;1014:3\u201343.","DOI":"10.1007\/978-1-62703-432-6_1"},{"issue":"5","key":"10.1016\/j.survophthal.2023.04.003_bib151","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/xen.12107","article-title":"hCTLA4-Ig transgene expression in keratocytes modulates rejection of corneal xenografts in a pig to non-human primate anterior lamellar keratoplasty model","volume":"21","author":"Vabres","year":"2014","journal-title":"Xenotransplantation"},{"issue":"1","key":"10.1016\/j.survophthal.2023.04.003_bib152","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1089\/ten.teb.2013.0100","article-title":"In situ tissue regeneration: chemoattractants for endogenous stem cell recruitment","volume":"20","author":"Vanden Berg-Foels","year":"2014","journal-title":"Tissue Eng Part B Rev"},{"issue":"4","key":"10.1016\/j.survophthal.2023.04.003_bib153","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1136\/jmedgenet-2019-106172","article-title":"Analysis of genotype-phenotype correlations in PAX6-associated aniridia","volume":"58","author":"Vasilyeva","year":"2021","journal-title":"J Med Genet"},{"issue":"1","key":"10.1016\/j.survophthal.2023.04.003_bib154","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1186\/s13287-021-02673-3","article-title":"Corneal epithelial differentiation of human pluripotent stem cells generates ABCB5(+) and Np63alpha(+) cells with limbal cell characteristics and high wound healing capacity","volume":"12","author":"Vattulainen","year":"2021","journal-title":"Stem Cell Res Ther"},{"issue":"13","key":"10.1016\/j.survophthal.2023.04.003_bib155","doi-asserted-by":"crossref","first-page":"5531","DOI":"10.1167\/iovs.18-25175","article-title":"Altered signaling pathways in aniridia-related keratopathy","volume":"59","author":"Vicente","year":"2018","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2023.04.003_bib156","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.omtn.2017.05.002","article-title":"Efficacy of postnatal in vivo nonsense suppression therapy in a Pax6 mouse model of aniridia","volume":"7","author":"Wang","year":"2017","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.survophthal.2023.04.003_bib157","article-title":"Phenotypic variation in a four-generation family with aniridia carrying a novel PAX6 mutation","volume":"2018","author":"Wang","year":"2018","journal-title":"J Ophthalmol"},{"issue":"1\u20133","key":"10.1016\/j.survophthal.2023.04.003_bib158","first-page":"6","article-title":"Human limbal epithelium contains side population cells expressing the ATP-binding cassette transporter ABCG2","volume":"565","author":"Watanabe","year":"2004","journal-title":"FEBS Lett"},{"key":"10.1016\/j.survophthal.2023.04.003_bib159","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ajo.2019.11.003","article-title":"Management of congenital aniridia-associated keratopathy: long-term outcomes from a tertiary referral center","volume":"210","author":"Yazdanpanah","year":"2020","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"10.1016\/j.survophthal.2023.04.003_bib160","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1097\/ICO.0000000000002264","article-title":"The use of autologous serum to reverse severe contact lens-induced limbal stem cell deficiency","volume":"39","author":"Yeh","year":"2020","journal-title":"Cornea"},{"key":"10.1016\/j.survophthal.2023.04.003_bib161","doi-asserted-by":"crossref","DOI":"10.1038\/hgv.2015.52","article-title":"Genotype-phenotype correlation of PAX6 gene mutations in aniridia","volume":"3","author":"Yokoi","year":"2016","journal-title":"Hum Genome Var"},{"key":"10.1016\/j.survophthal.2023.04.003_bib162","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.omtn.2018.08.018","article-title":"Protecting Pax6 3\u2032 UTR from microRNA-7 partially restores PAX6 in Islets from an aniridia mouse model","volume":"13","author":"Yongblah","year":"2018","journal-title":"Mol Ther Nucleic Acids"},{"issue":"12","key":"10.1016\/j.survophthal.2023.04.003_bib163","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1002\/humu.22907","article-title":"Variants in TRIM44 cause aniridia by impairing PAX6 expression","volume":"36","author":"Zhang","year":"2015","journal-title":"Hum Mutat"},{"issue":"1","key":"10.1016\/j.survophthal.2023.04.003_bib164","article-title":"BTLA suppress acute rejection via regulating TCR downstream signals and cytokines production in kidney transplantation and prolonged allografts survival","volume":"9","author":"Zhang","year":"2019","journal-title":"Sci Rep"}],"updated-by":[{"DOI":"10.1016\/j.survophthal.2024.01.001","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000}}],"container-title":["Survey of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625723000668?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625723000668?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T20:32:10Z","timestamp":1729024330000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039625723000668"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":164,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S0039625723000668"],"URL":"https:\/\/doi.org\/10.1016\/j.survophthal.2023.04.003","relation":{},"ISSN":["0039-6257"],"issn-type":[{"value":"0039-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Future directions in managing aniridia-associated keratopathy","name":"articletitle","label":"Article Title"},{"value":"Survey of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.survophthal.2023.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}